How can we help?

MAMMALIAN CELL TECHNOLOGY

Bioneer assists clients in the pre-clinical and early clinical phases with production of recombinant proteins in a variety of mammalian cell systems, with access to existing or development of novel functional assays based upon mammalian cells as well as general technology development, e.g. bioreactor evaluation, biobanking, and cell handling. In fact, we can support our clients in the entire process of bringing a novel biologic compound from the laboratory through pre-clinical evaluation for functionality and safety.

IMMUNE TARGETING

Bioneer offers evaluation of compounds using mainly three cell systems 1) Primary dendritic cells (human and murine) 2) Peripheral blood mononuclear cells (PBMCs) and 3) cell line based models. We provide services in our model systems in the discovery process (mainly evaluation of mechanism of action and immune modulation and suppression of specific inflammatory responses) as well as activities involved in the development process (mainly evaluation of safety of IV administered drugs, and assessment of potency).

PROTEIN MANUFACTURING

Bioneer addresses a client's needs for limited amounts of recombinant proteins, e.g. during the discovery phase and preclinical phase of biologics development.

DRUG DEVELOPMENT

Turning an active compound into a drug product

Pharmaceutical services, covering the field from lead identification to final formulation of the active compound, are provided by Bioneer:FARMA.

Bioneer:FARMA is a business unit of Bioneer established in collaboration with the Faculty of Pharmaceutical Sciences (FARMA), University of Copenhagen, Denmark.

BIOMARKERS

Bioneer offers a range of services related to the identification, validation and documentation of disease relevant biomarkers and drug targets. These services comprise a toolbox of molecular methods that will facilitate the pre-clinical development of both biomarkers, drug-targets and active compounds, which will be useful in diagnostic, prognostic, and therapeutic contexts, and, furthermore, serve as effective means to optimize clinical trial designs.

DYNAMIC GASTRIC MODEL

The Dynamic Gastric Model is the first true "dynamic" in-vitro model of the human stomach that fully replicates the complex biochemical conditions and the array of gastric forces crucial for the prediction of oral pharmaceuticals and food products

News:

2016-06-11:
Welcome to Vibeke Dalhoff

Vibeke Dalhoff joined Bioneer on 1 May 2016

Read more
2016-06-10:
Welcome to Lovisa Sunesson

Lovisa Sunesson, PhD, BD joined Bioneer's Business Development on 1 May 2016.

Read more
2016-06-10:
Human in vitro models simulate interplay between dendritic cells and T cells

Bioneer develops human in vitro models that simulate the interplay between dendritic cells and T cells as it takes place in a tumor microenvironment.

Read more
READ MORE NEWS

Meet us at:

Nordic Life Science Days 14 - 15 Sept 2016
Bioneer attends NLSDays in Stockholm Sept 14 to 15, 2016
Read more
European Biotechnology Conference 2016
Meet Bioneer @ ECB 2016 i Krakow July 3 - 7.
Read more
Other places to meet us